Amolab serves the global medical community to offer innovative, safe, automated and non-invasive technology solutions.
The most advanced ultrasound scanning technologies (applied in the pulmonology and obstetrics-gynaecology fields) to support healthcare professionals in their daily care of their patients.
Amolab is constantly developing integrated hardware and software solutions to make innovative devices available to clinicians.
Ultrasound scans are guided by Artificial Intelligence, the ‘digital brain’ of Amolab’s innovative devices that is one of their most qualifying strengths.
The software enables the acquisition and processing of images by automatically returning diagnostic indicators and assessments that recent research has shown to be substantially superimposable on the conclusions of ‘human’ medical specialists.
Technological innovation applied to the medical world. Amolab, founded in Lecce in 2011 as a spin-off of the National Research Council, specialises in finding new solutions for diagnostic imaging.
Registered in the special section of the Innovative Companies Register, the company has several patents for industrial invention in the field of medical devices.
Amolab uses management systems that comply with the guidelines issued by the International Organisation for Standardisation (ISO) in its business processes, in order to improve effectiveness and efficiency in the realisation of products and services and achieve customer satisfaction.
In particular, the company applies the quality standards required for the production and marketing of medical devices, such as our sophisticated diagnostic imaging devices.
We must not let our guard down during the post-Covid phase since it continues to be an extreme danger. Because of this, we are including SensUS Lung in our telemedicine and telemonitoring network
SensUS Lung is a portable medical device that allowed us to visit patients who couldn’t move to Athens or needed immediate treatment. Thanks to SensUS Lung, a device based on artificial intelligence, we were able to help a lot of them and so I think it needs to continue to be used
SenseUS Lung is a light-and-easy-to-handle diagnostic device, able to adapt to the patient’s needs; crucial characteristics in emergencies. It allows standardised and accurate exploration of the thorax, overcoming the limitations of an operator-dependent examination and guaranteeing homogeneous results.
We have a very positive experience in our delivery room with SensUS Touch: we are lucky because we have a state-of-the-art device that allows doctors and midwives to get a quick objective analysis, through scans lasting just a few seconds, of the progress of labour and the progression of the fetus along the birth canal. This is extremely helpful to recognize the management of operative deliveries more easily and in a timely manner in the event of dystocia.
The SensUS Touch device is a very useful instrument for managing labour, since it allows us to objectively measure certain parameters related to the progression of the fetal head in the birth canal.
SensUS makes it possible to obtain an objective, numerical datum, which is memorised and reported in special cards in the medical records and this is also important from a medical-legal point of view because it reduces the risk of litigation.
The use of SensUS Lung, especially during the pandemic phase, has been very important and an invaluable support: it provides numerical data that is more comparable than ocular data, and this is especially useful when applied to since it is an extremely operator-dependent examination.
The use of SensUS Lung is important during the pre and post infected state and also through the follow-up monitoring of pneumonia, including Covid-19 pneumonia. It allows automatic identification with a 14-zone scan of the lung, zone-by-zone staging with the pneumonia score and a customized monitoring.
SensUS Lung had demonstrated important potential for the diagnosis of pneumonia, including the one caused by Covid 19, and will be used in both pulmonology and cardiology to diagnose pericardial effusions.
In case of a cardiological disfunction, upstream, in the lungs, fluid accumulates: this could lead to a typical ultrasound finding, considering* the so called “wet lung disease”. The combination of the cardiological and pulmonary evaluations, made objectively and independently from the operator, allows us to have all the correct information on the severity of the condition.
Amolab starts the regulatory process for Qatar
The requests for authorizations required by the legal provisions... read more
Engineer Giuseppe di Giuseppe, President of the Italian Society of Telemedicine (Sec. Apulia)
We are now conducting experimental work in Foggia along... read more
Doc. Claudio Lopriore – General Director of Cardio on line Europe S.r.l.
We must not let our guard down during the... read more
Prof. Andrea Dall’Asta, associate professor of Gynecology and Obstetrics at the University of Parma
SensUS Touch makes it possible to track the fetus’... read more